Effect of Methylenedioxymethamphetamine (MDMA) (Serotonin Release) on Fear Extinction
Clinical trial NCT03527316 · COMPLETED
Trial details
- NCT number
- NCT03527316
- Sponsor
- University Hospital, Basel, Switzerland
- Status
- COMPLETED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-18
- Primary completion
- 2020-12-10
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.